These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18950505)

  • 1. Determining the impact of alternative splicing events on transcriptome dynamics.
    Wilhelm E; Pellay FX; Benecke A; Bell B
    BMC Res Notes; 2008 Oct; 1():94. PubMed ID: 18950505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide detection of testis- and testicular cancer-specific alternative splicing.
    He C; Zuo Z; Chen H; Zhang L; Zhou F; Cheng H; Zhou R
    Carcinogenesis; 2007 Dec; 28(12):2484-90. PubMed ID: 17724370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide detection and analysis of alternative splicing for nucleotide binding site-leucine-rich repeats sequences in rice.
    Gu L; Guo R
    J Genet Genomics; 2007 Mar; 34(3):247-57. PubMed ID: 17498622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative splicing: global insights.
    Hallegger M; Llorian M; Smith CW
    FEBS J; 2010 Feb; 277(4):856-66. PubMed ID: 20082635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing.
    Pan Q; Shai O; Lee LJ; Frey BJ; Blencowe BJ
    Nat Genet; 2008 Dec; 40(12):1413-5. PubMed ID: 18978789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splicing for alternative structures of Cav1.2 Ca2+ channels in cardiac and smooth muscles.
    Liao P; Yong TF; Liang MC; Yue DT; Soong TW
    Cardiovasc Res; 2005 Nov; 68(2):197-203. PubMed ID: 16051206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array.
    Gardina PJ; Clark TA; Shimada B; Staples MK; Yang Q; Veitch J; Schweitzer A; Awad T; Sugnet C; Dee S; Davies C; Williams A; Turpaz Y
    BMC Genomics; 2006 Dec; 7():325. PubMed ID: 17192196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching on transgene expression by correcting aberrant splicing using multi-targeting steric-blocking oligonucleotides.
    Resina S; Kole R; Travo A; Lebleu B; Thierry AR
    J Gene Med; 2007 Jun; 9(6):498-510. PubMed ID: 17471591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of splice-switching oligonucleotides.
    Bauman J; Jearawiriyapaisarn N; Kole R
    Oligonucleotides; 2009 Mar; 19(1):1-13. PubMed ID: 19125639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new advance in alternative splicing databases: from catalogue to detailed analysis of regulation of expression and function of human alternative splicing variants.
    de la Grange P; Dutertre M; Correa M; Auboeuf D
    BMC Bioinformatics; 2007 Jun; 8():180. PubMed ID: 17547750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pre-mRNA alternative splicing in cancer: functional impact, molecular mechanisms and therapeutic perspectives].
    Revil T; Shkreta L; Chabot B
    Bull Cancer; 2006 Sep; 93(9):909-19. PubMed ID: 16980234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolving roles of alternative splicing.
    Lareau LF; Green RE; Bhatnagar RS; Brenner SE
    Curr Opin Struct Biol; 2004 Jun; 14(3):273-82. PubMed ID: 15193306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative splicing in cancer: noise, functional, or systematic?
    Skotheim RI; Nees M
    Int J Biochem Cell Biol; 2007; 39(7-8):1432-49. PubMed ID: 17416541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splicing in the immune system: potential targets for therapeutic intervention by antisense-mediated alternative splicing.
    Mourich DV; Iversen PL
    Curr Opin Mol Ther; 2009 Apr; 11(2):124-32. PubMed ID: 19330718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of pre-mRNA splicing in cancer.
    Kalnina Z; Zayakin P; Silina K; Linē A
    Genes Chromosomes Cancer; 2005 Apr; 42(4):342-57. PubMed ID: 15648050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ECgene: genome annotation for alternative splicing.
    Kim P; Kim N; Lee Y; Kim B; Shin Y; Lee S
    Nucleic Acids Res; 2005 Jan; 33(Database issue):D75-9. PubMed ID: 15608289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splice variants as cancer biomarkers.
    Brinkman BM
    Clin Biochem; 2004 Jul; 37(7):584-94. PubMed ID: 15234240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach.
    Bainbridge MN; Warren RL; Hirst M; Romanuik T; Zeng T; Go A; Delaney A; Griffith M; Hickenbotham M; Magrini V; Mardis ER; Sadar MD; Siddiqui AS; Marra MA; Jones SJ
    BMC Genomics; 2006 Sep; 7():246. PubMed ID: 17010196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics--gene silencing.
    Lele RD
    J Assoc Physicians India; 2009 Jan; 57():60-6. PubMed ID: 19753761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Tak1 alternative splicing by splice-switching oligonucleotides.
    Zhou D; Shao Q; Fan X; Wu P; Lin W; Wei H; He F; Jiang Y
    Biochem Biophys Res Commun; 2018 Mar; 497(4):1018-1024. PubMed ID: 29475001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.